Skip to main content
Premium Trial:

Request an Annual Quote

Structural Bioinformatics Uses Sequence Data to Generate Lead Molecules


SAN DIEGO, Calif.--Applying its proprietary protein-modeling technology to gene sequence data, Structural Bioinformatics here has developed a number of small-molecule nonpeptide lead molecules in multiple chemical classes that are active against the EPO receptor, the company announced recently. To find leads for a variety of structure-based drug design projects, Structural uses an analysis of target sites on a protein structure together with virtual screening. When no 3-D protein structure is available, analyses are performed on a high-quality protein model based in part on related protein structures and augmented with proprietary loop modeling and other refinements.

Edward Maggio, Structural's CEO, called the new development "another validation of our proprietary protein-modeling approach to drug design that permits rapid generation of novel leads from gene sequence for which no protein crystal structures are available."

Filed under

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.